Humana Inc. (NYSE: HUM) CEO Bruce Broussard will step down in late 2024, with incoming COO and President Jim Rechtin on deck to succeed him. Rechtin comes to Humana from Envision Healthcare where he is now president and CEO. He transitions to the COO role for the insurance behemoth as of Jan. 8, 2024 and […]
Thus far in 2023, hospice merger and acquisition activity has deviated from prior years. This year is distinctive because of factors such as valuations, asset sizes and the mix of buyers. A number of trends have shifted. The last five years saw record-breaking multiples in the hospice space and private equity-backed platform deals were among […]
On the heels of its $710 million acquisition of Heartland Hospice, Gentiva has opened a do novo in Mississippi. The new location will serve 10 Mississippi counties, adding to the company’s more than 430 locations across 38 states. “It is amazing and today it is groundbreaking to come out here in the community,” the location’s […]
Regulatory challenges have contributed to the hospice sector’s current M&A slump, but this year’s volume nevertheless aligns with experts’ forecasts. In addition to those pressures, the industry is also in a cooling period in which companies focus on integrating the assets that many acquired during flurries of activity in 2021 and 2022, according to Mark […]
Hospice merger and acquisition activity has taken a downturn in 2023, which is in line with projections from M&A experts. Approximately 14 hospice, home care and home health transactions were reported during the first quarter of 2023, according to recent data from Mertz Taggart. Less than a handful (about 4 or 5) of these were […]
Following its hospice divestiture, Humana’s (NYSE: HUM) health care services business, CenterWell, is poised for growth, with demand for acute senior home care as a driver. Humana anticipates expansion across each of CenterWell’s business lines, which encompasses the insurance mammoth’s home health, primary care, pharmacy and specialty pharmacy services. The segment also includes a joint […]
Hospice transaction activity has plummeted to its lowest level in years, new dealmaking data suggests. That’s no surprise, as many anticipate health care investors to operate with a more conservative approach in 2023. The cooldown, experts note, is partly due to inflation reaching multi-decade highs, uncertainty in the banking world and credit markets drying up. […]
Gentiva’s recent $710 million acquisition of ProMedica’s hospice and home-based care assets bucks prevailing trends in today’s M&A market. Transaction volume dipped during 2022, specifically when it came to large platform deals by private equity firms. Many in the space expect smaller deals to become more prevalent during the first half of 2023, particularly in […]
The hospice, palliative care and personal care provider Gentiva has agreed to acquire Heartland Hospice and other assets from the nonprofit health system ProMedica. Heartland is valued at $710 million, Bloomberg reported. Gentiva is a portfolio company of the private equity firm Clayton, Dubilier & Rice (CDR). The Atlanta-based provider emerged from the former hospice […]
Though investors and strategic buyers didn’t wade quite as deep into the hospice market in 2022 compared to years prior, the tide may be rising for M&A during 2023. Though hospice M&A activity fluctuated last year, volume is expected to rebound, but probably with larger numbers of smaller deals. Swelling demand for hospice and home […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
